Inventor · disambiguated record
Edward C. Lawson
Also filed as: LAWSON EDWARD · LAWSON EDWARD C · LAWSON EDWARD CHARLES
19 granted patents·2 pending applications·31 citations·filing 1999–2023
90Inventor score
Files withJANSSEN PHARMACEUTICA NV10MARYANOFF BRUCE E3KINNEY WILLIAM A2ORTHO MCNEIL PHARM INC2GRECO MICHAEL N1
Top patents by PatentIndex Score
21 records- 0191US10653711B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 19, 2020·6 cites·18 claims
- 0283US11318157B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted May 3, 2022·1 cites·4 claims
- 0380US8193191B2Urotensin II receptor antagonistsMARYANOFF BRUCE E·Filed 2011·Granted Jun 5, 2012·5 cites·26 claims
- 0478US8008299B2Urotensin II receptor antagonistsJANSSEN PHARMACEUTICA NV·Filed 2008·Granted Aug 30, 2011·3 cites·19 claims
- 0577US2024124493A1Monocyclic And Bicyclic Ring System Substituted Carbanucleoside Analogues For Use As PRMT5 InhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 0677US2023330127A16-6 bicyclic aromatic ring substituted nucleoside analogues for use as prmt5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 0774US11883367B26-6 bicyclic aromatic ring substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jan 30, 2024·0 cites·19 claims
- 0874US7915260B2Urotensin II receptor antagonistsMARYANOFF BRUCE E·Filed 2007·Granted Mar 29, 2011·3 cites·28 claims
- 0972US7618983B2Bicyclic triazole α4 integrin inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2005·Granted Nov 17, 2009·1 cites·36 claims
- 1068US11993614B2Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted May 28, 2024·0 cites·16 claims
- 1160US11098062B2Monocyclic and bicyclic ring system substituted carbanucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 24, 2021·0 cites·6 claims
- 1259US8552032B2Bicyclic derivatives useful as inhibitors of DPP-1LAWSON EDWARD C·Filed 2010·Granted Oct 8, 2013·1 cites·24 claims
- 1354US6303625B1Triazolopyridines for the treatment of thrombosis disordersORTHO MCNEIL PHARM INC·Filed 1999·Granted Oct 16, 2001·11 cites·23 claims
- 1452US8536174B2Urotensin II receptor antagonistsMARYANOFF BRUCE E·Filed 2012·Granted Sep 17, 2013·0 cites·23 claims
- 1551US9079896B2Urotensin II receptor antagonistsKINNEY WILLIAM A·Filed 2009·Granted Jul 14, 2015·0 cites·6 claims
- 1645US8445514B2Urotensin II receptor antagonistsKINNEY WILLIAM A·Filed 2011·Granted May 21, 2013·0 cites·13 claims
- 1744US10898504B2Substituted nucleoside analogues for use as PRMT5 inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Jan 26, 2021·0 cites·17 claims
- 1841US8476302B2α-ketoamide derivatives useful endothelial lipase inhibitorsGRECO MICHAEL N·Filed 2011·Granted Jul 2, 2013·0 cites·17 claims
- 1941US7081460B2Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disordersORTHO MCNEIL PHARM INC·Filed 2002·Granted Jul 25, 2006·0 cites·45 claims
- 2037US8759342B2Benzo[1,4]oxazin-3-one, benzo[1,4]thiazin-3-one and quinolin-2-one urotensin II receptor antagonistsSHYAMALI GHOSH·Filed 2007·Granted Jun 24, 2014·0 cites·32 claims
- 2133US8633322B2Alkynyl derivatives useful as DPP-1 inhibitorsPARKER MICHAEL H·Filed 2010·Granted Jan 21, 2014·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →